NovoSorb BTM approved for sale in Saudi Arabia
Filed with ASX · · 1 page · English
Earlier from PolyNovo
- Final patient enrolled in CE Mark Burn Trial
- PolyNovo Announces Breast Device Development Program
- Results announcement, App 4D and Half-Year Financial Report
- PolyNovo Announces Breast Device Development Agreement
- PolyNovo signs MOU for global breast partnership
Later from PolyNovo
- Final Patient enrolled in BARDA Feasibility Burn Trial
- Annual Report to Shareholders and Appendix 4E
- S&P DJI Announces September 2018 Quarterly Rebalance
- NovoSorb BTM aaproved for sale in India
- AGM Chairman and CEO Address to Shareholders
Follow PolyNovo into a list and get an email when it puts out news.
Follow PolyNovo